Pharmaceutical Industry Today
Europe Narcolepsy Market Grows Tremendously By 2019-2027 with CAGR value of 9.7% and Impact of Covid-19| Teva Pharmaceuticals, Jazz Pharmaceuticals, Arena Pharmaceuticals, Novartis
Narcolepsy is a rare chronic sleep disorder that is caused due to the loss of neurons that produces hypocretin. Various developments have been made to make medicines that can reduce the symptoms of narcolepsy.
Published 14 September 2021
Europe narcolepsy market is anticipated to reach US$ 1,532.5 Mn in 2027 from US$ 671.1Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.7% from 2019-2027. The narcolepsy market is estimated to grow due to the key driving factors such as growing research and developments and increasing awareness across the region. However, the factor such as challenges related to narcolepsy is likely to act as major restraining factor for the growth of the market.
Several research and developments are being conducted across countries such as Germany, the UK, and other countries in the European region. For instance, in April 2019, in Germany, research and development activities were carried out at Inserm and Université de Montpellier. The research was conducted in collaboration with international teams that helped to conducted studies for epidemiological and clinical research for the drug Solriamfetol among the people living with narcolepsy.
Obtain a Sample Brochure at – https://www.businessmarketinsights.com/sample/TIPRE00008098
The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years. Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the regional industry player and helps the companies to garner Europe Narcolepsy market revenue by understanding the strategic growth approaches.
Leading Europe Narcolepsy market Players:
Europe Narcolepsy – Market Segmentation
Europe Narcolepsy Market – By Type
Reason to Buy
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact US:
Business Market Insights
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/
LinkedIn URL: https://www.linkedin.com/company/business-market-insights/
Several research and developments are being conducted across countries such as Germany, the UK, and other countries in the European region. For instance, in April 2019, in Germany, research and development activities were carried out at Inserm and Université de Montpellier. The research was conducted in collaboration with international teams that helped to conducted studies for epidemiological and clinical research for the drug Solriamfetol among the people living with narcolepsy.
Obtain a Sample Brochure at – https://www.businessmarketinsights.com/sample/TIPRE00008098
The report covers the prominent players in the market with detailed SWOT analysis, financial overview, and key developments of the products/services from the past three years. Moreover, the report also offers a 360º outlook of the market through the competitive landscape of the regional industry player and helps the companies to garner Europe Narcolepsy market revenue by understanding the strategic growth approaches.
Leading Europe Narcolepsy market Players:
- Teva Pharmaceutical Industries Ltd.
- Jazz Pharmaceuticals plc
- Arena Pharmaceuticals, Inc.
- Graymark Healthcare, Inc.
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- BIOPROJET
- Shionogi & Co., Ltd.
- Ligand Pharmaceuticals, Inc
Europe Narcolepsy – Market Segmentation
Europe Narcolepsy Market – By Type
- Narcolepsy with Cataplexy
- Narcolepsy without Cataplexy
- Secondary Narcolepsy
- Central Nervous System (CNS) Stimulants
- Sodium Oxybate
- Antidepressants
- Hospital Pharmacies
- Retail Pharmacies
- Europe
- US
- Canada
- Mexico
Reason to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the regional Europe Narcolepsy market.
- Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Narcolepsy market, thereby allowing players to develop effective long term strategies in order to garner their market revenue.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.
- Enhance the decision-making process by understanding the strategies that is commercial interest with respect to products, segmentation and industry verticals.
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
Contact US:
Business Market Insights
Phone: +442081254005
E-Mail ID: sales@businessmarketinsights.com
Web URL: https://www.businessmarketinsights.com/
LinkedIn URL: https://www.linkedin.com/company/business-market-insights/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!